Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Kaichun Wu

Matched on ORCID iD 0000-0002-0699-9666; OpenAlex author ID A5078303906. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 8

  1. Irradiation of 125I seeds blocks glycolysis in pancreatic cancer by inhibiting KLF5 m6A methylation through the suppression of RBM15. Co-author DOI 10.1016/j.yexcr.2025.114538↗
  2. Insulin promotes the proliferation and migration of pancreatic cancer cells by up-regulating the expression of PLK1 through the PI3K/AKT pathway. Co-author DOI 10.1016/j.bbrc.2023.01.061↗
  3. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Co-author DOI 10.1038/s42003-021-02557-5↗
  4. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2020.7615↗
  5. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.17701↗
  6. Rapamycin inhibits the proliferation of SW1990 pancreatic cancer cell. Co-author PMID 26367731↗
  7. Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins. Co-author DOI 10.1016/j.bbrc.2013.09.079↗
  8. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Co-author DOI 10.1016/j.clinbiochem.2012.05.012↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunzhao Yu · 2 shared papers, 2020–2023 · strength 0.35
  2. Jianjun Song · 1 shared paper, 2025 · strength 0.28
  3. Feng Wang · 1 shared paper, 2025 · strength 0.28
  4. Yue Fu · 1 shared paper, 2023 · strength 0.24
  5. Xiang Cao · 1 shared paper, 2023 · strength 0.24
  6. Xiangyin Kong · 1 shared paper, 2021 · strength 0.11
  7. Wei Guo · 1 shared paper, 2021 · strength 0.11
  8. Shiwei Guo · 1 shared paper, 2021 · strength 0.11
  9. Yuchao Zhang · 1 shared paper, 2021 · strength 0.11
  10. Yufei Zhu · 1 shared paper, 2021 · strength 0.11
  11. Gang Jin · 1 shared paper, 2021 · strength 0.11
  12. Wulin Wang · 1 shared paper, 2020 · strength 0.11
  13. Sheng Wang · 1 shared paper, 2020 · strength 0.11
  14. Hao Hui Chen · 1 shared paper, 2020 · strength 0.11
  15. Wang Xp · 1 shared paper, 2015 · strength 0.06
  16. Mingjuan Xu · 1 shared paper, 2015 · strength 0.06
  17. Daiming Fan · 2 shared papers, 2012–2013 · strength 0.06
  18. Jiayu Liu · 1 shared paper, 2017 · strength 0.06
  19. Zhaoyan Qiu · 1 shared paper, 2017 · strength 0.06
  20. Gang Wang · 1 shared paper, 2017 · strength 0.06
  21. Jie Liang · 1 shared paper, 2017 · strength 0.06
  22. Xuegang Guo · 1 shared paper, 2013 · strength 0.03
  23. Linhong Deng · 1 shared paper, 2013 · strength 0.03
  24. Lin Zhang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.